| Drug Name |
Dobutamine hydrochloride |
| Drug ID |
BADD_D00698 |
| Description |
A beta-1 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery. |
| Indications and Usage |
For inotropic support in the short- term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
C01CA07 |
| DrugBank ID |
DB00841
|
| KEGG ID |
D00632
|
| MeSH ID |
D004280
|
| PubChem ID |
65324
|
| TTD Drug ID |
D0J7RK
|
| NDC Product Code |
0338-1077; 51662-1566; 50090-4562; 12711-4820; 14335-170; 0338-1075; 0338-1073 |
| Synonyms |
Dobutamine | Dobucor | Dobuject | Dobutamin Fresenius | Dobutamin Hexal | Dobutamin Solvay | Dobutamin-ratiopharm | Dobutamin ratiopharm | Dobutamina Inibsa | Dobutamina Rovi | Posiject | Dobutamine Hydrobromide | Hydrobromide, Dobutamine | Dobutamine Hydrochloride | Hydrochloride, Dobutamine | Dobutamine Lactobionate | Lactobionate, Dobutamine | Dobutamine Tartrate | Tartrate, Dobutamine | Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer | Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer | Dobutamine, (-)-Isomer | Dobutamine, Phosphate (1:1) Salt (+)-Isomer | Dobutrex | Lilly 81929 | Oxiken | Dobutamine Phosphate (1:1) Salt, (-)-Isomer | Dobutamine (+)-Isomer |
